Search

everythinglearnresearchcommunity

for

Search:↓

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

A woman kept her eyelashes during chemotherapy possibly because of her glaucoma eye drops.

Endoxan often causes hair loss, which usually starts in the third week of treatment.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

Retinol palmitate may reduce cancer relapses in early-stage lung cancer patients.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Conditioners in hair dye reduce damage and improve combability.

Inhibiting the PI3K/Akt pathway may help prevent radiation-induced liver injury.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Image analysis can effectively identify changes in scalps affected by chemotherapy-induced hair loss.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

A lotion with natural extracts significantly sped up hair growth in women with hair loss from chemotherapy.

A man had bad reactions to a hair loss treatment called DNCB.

Asian women with breast cancer experience the highest rates of long-term hair loss and related distress after chemotherapy.

Cell extracts may effectively and safely repair radiation-damaged salivary glands.

Using radiation to make mice's hair turn gray helps study and find ways to prevent or reverse hair graying.

Eyelash loss can temporarily occur from chemotherapy for retinoblastoma.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Plant-based medicines can effectively prevent and treat cancer with fewer side effects.

Inhibiting ornithine decarboxylase may help prevent certain skin cancers.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Cancer patients in sub-Saharan Africa face significant challenges during chemotherapy, highlighting the need for better patient care and support.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

CDK4/6 inhibitors affect safety and quality of life differently, requiring careful use.

Most women undergoing chemotherapy experience hair loss, and many cope by using wigs or bonnets.

Minoxidil and a solvent mixture can prevent hair loss caused by chemotherapy in mice.